Primary dysmenorrhoea. Primary dysmenorrhoea
Conditions
Interventions
Intervention 1: Group 1 will receive Fenellin, 30 drops every 4 hours beginning one day before the start of the cycle until the third day. Intervention 2: Group 4 will receive Placebo, 30 drops every
Placebo
Treatment - Drugs
Group 1 will receive Fenellin, 30 drops every 4 hours beginning one day before the start of the cycle until the third day
Group 4 will receive Placebo, 30 drops every 4 hours beginning one day before the start of the cycle until the third day
Group 2 will receive Vitagnus 40 once a day in the morning beginning one day before the start of the cycle until the third day
Group 3 will receive Mefenamic acid 250 mg capsules every 4 hours beginning one day before the start of the cycle until the third day
Sponsors
Hamadan University of Medical Sciences
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Inclusion criteria: 1- Female student with primary dysmenorreha Exclusion criteria: 1-Any systemic disease such as liver, kidney, thyroid and coagulation disease 2- Hypersensitivity to drug 3- Use of analgesic drugs during the study 4- Use of OCP or IUD
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: The day before the menstrual cycle starts and day 1, 2, and 3 of the cycle in three successive cycles. Method of measurement: Visual Analogue Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Menstrual bleeding. Timepoint: Day 1, 2, and 3 of the menstrual cycle in three successive cycles. Method of measurement: Using Higam method. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactFatemeh Shobeiri
Hamadan University of Medical Sciences
Outcome results
None listed